Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
The author expresses a critical sentiment that the current valuations of orbio at $90M and surplus at $7M do not make sense. No specific price targets, timeframes, or additional financial data are provided.
Ask about this postAnswers are grounded in this post's content.